Zura Bio
ZURA
65 hedge funds and large institutions have $37.1M invested in Zura Bio in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 30 closing their positions.
12% less funds holding
Funds holding: 74 → 65 (-9)
15.2% less ownership
Funds ownership: 66.85% → 51.65% (-15%)
21% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 19
30% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 30
37% less capital invested
Capital invested by funds: $59M → $37.1M (-$21.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$2.45M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$677K |
| 3 |
Millennium Management
New York
|
+$581K |
| 4 |
Goldman Sachs
New York
|
+$215K |
| 5 |
Morgan Stanley
New York
|
+$198K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.15M |
| 2 |
AI
Allostery Investments
Stamford,
Connecticut
|
-$3M |
| 3 |
BlackRock
New York
|
-$2.56M |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$2.16M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$1.86M |
ZURA Hedge Fund Activity: Q2 2025 in Review
65 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q2 2025, worth a combined $37.1M — down 37% from $59M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of ZURA and 21 opened new positions — a net loss of 9 holders — while 19 trimmed existing stakes and 15 added.
The largest buyer was JP Morgan Chase, adding an estimated $2.45M. The largest seller was RA Capital Management, exiting entirely with an estimated $4.15M sold.
- 65 institutional investors held Zura Bio (ZURA) as of Q2 2025, down from 74 in Q1 2025.
- Funds reported $37.1M of Zura Bio stock for Q2 2025, down 37% quarter-over-quarter.
- 21 funds opened new Zura Bio positions in Q2 2025 and 30 closed out, a net change of -9 holders.
- The largest Zura Bio buyer in Q2 2025 was JP Morgan Chase, an estimated $2.45M added.
- The largest Zura Bio seller in Q2 2025 was RA Capital Management, an estimated $4.15M sold.
Based on aggregated 13F filings for Q2 2025.